Joseph Carleone - 31 Mar 2025 Form 4 Insider Report for SENSIENT TECHNOLOGIES CORP (SXT)

Role
Director
Signature
/s/ John J. Manning, Attorney-in-Fact for Dr. Carleone
Issuer symbol
SXT
Transactions as of
31 Mar 2025
Net transactions value
$0
Form type
4
Filing time
01 Apr 2025, 15:42:22 UTC
Previous filing
07 Feb 2025
Next filing
28 Apr 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding SXT Common Stock 19,899 31 Mar 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SXT Deferred Stock Award $0 +491 +2.3% $0.000000 21,840 31 Mar 2025 Common Stock 491 Direct F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes shares of restricted stock held under Issuer's 2017 Stock Plan, as amended and restated, and shares held in a dividend reinvestment plan.
F2 Deferred stock converts to common stock on a one-for-one basis.
F3 Deferral of director fees under Issuer's Directors' Deferred Compensation Plan.
F4 Shares of common stock will be issued upon termination of reporting person's service as a director of the Issuer.